Skip to search formSkip to main contentSkip to account menu

Amlodipine / valsartan

Known as: Amlodipine Valsartan, Valsartan, Amlodipine -, - Valsartan, Amlodipine 
A pharmaceutical preparation of amlodipine and valsartan that is used for the treatment of HYPERTENSION.
National Institutes of Health

Related topics

Related topics

11 relations
AmlodipineIn Bloodagonistsanalogs & derivatives

Broader (1)

Antihypertensive Agents

Narrower (1)

Exforge

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
Effects of angiotensin-neprilysin inhibition compared to angiotensin inhibition on ventricular arrhythmias in reduced ejection fraction patients under continuous remote monitoring of implantable…
Highly Cited
2015
Highly Cited
2015
Efficacy and safety of LCZ696 (sacubitril-valsartan) according to age: insights from PARADIGM-HF
Background The age at which heart failure develops varies widely between countries and drug tolerance and outcomes also vary by… 
Highly Cited
2012
Highly Cited
2012
Formulation and optimization of nanotransfersomes using experimental design technique for accentuated transdermal delivery of valsartan.
Highly Cited
2010
Highly Cited
2010
Amlodipine-Valsartan Combination Decreases Central Systolic Blood Pressure More Effectively Than the Amlodipine-Atenolol Combination: The EXPLOR Study
The &bgr;-blocker atenolol is less effective than angiotensin-receptor blockers and calcium-channel blockers for reducing central… 
Highly Cited
2010
Highly Cited
2010
Preparation and Bioavailability Assessment of SMEDDS Containing Valsartan
A self-microemulsifying drug delivery system (SMEDDS) has been developed to enhance diffusion rate and oral bioavailability of… 
Highly Cited
2008
Highly Cited
2008
Reduced incidence of new-onset atrial fibrillation with angiotensin II receptor blockade: the VALUE trial
Background Atrial fibrillation (AF) is the most common arrhythmia and increases cardiovascular risk in hypertensive patients… 
Highly Cited
2008
Highly Cited
2008
Efficacy of the Combination of Amlodipine and Valsartan in Patients With Hypertension Uncontrolled With Previous Monotherapy: The Exforge in Failure After Single Therapy (EX‐FAST) Study
In this randomized, double‐blind, multicenter study, patients whose blood pressure (BP) was uncontrolled by monotherapy were… 
Highly Cited
2006
Highly Cited
2006
Outcomes in subgroups of hypertensive patients treated with regimens based on valsartan and amlodipine: an analysis of findings from the VALUE trial
Background In the Valsartan Antihypertensive Long-term Use Evaluation (VALUE) trial the primary outcome (cardiac morbidity and… 
Highly Cited
2000
Highly Cited
2000
Maximally recommended doses of angiotensin-converting enzyme (ACE) inhibitors do not completely prevent ACE-mediated formation of angiotensin II in chronic heart failure.
BACKGROUND The added benefits of angiotensin II type I receptor (AT(1)) blockers (ARBs) to ACE inhibition suggests that… 
Highly Cited
1996
Highly Cited
1996
Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: A comparative study of the efficacy and safety against amlodipine
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)